Citius Pharmaceuticals Intrinsic Value – Avoid Citius Pharmaceuticals: A Cautionary Tale
🌧️Trending News When it comes to investing in the stock market, it is always best to err on the side [...]
Sino Biological Unit to Lease Beijing Property to Shenzhou Cell Engineering
🌥️Trending News The Sino Biological ($SZSE:301047) Unit is pleased to announce that they will be leasing a Beijing property to [...]
Kiora Pharmaceuticals Stock Fair Value – Kiora Pharmaceuticals Stock Plummets 50% Following $5.5M Public Offering
🌥️Trending News Kiora Pharmaceuticals ($NASDAQ:KPRX), a biopharmaceutical company focused on the development of innovative treatments for serious diseases, has recently [...]
Autolus Therapeutics Shares Rise After Presentation of Positive Phase 2 Leukemia Therapy Data
☀️Trending News Autolus Therapeutics ($NASDAQ:AUTL), a biopharmaceutical company developing next-generation T-cell therapies for the treatment of cancer, recently presented data [...]
Lixte Biotechnology Stock Intrinsic Value – LIXTE Biotechnology Holdings Announces Reverse Stock Split to Comply with Minimum Price Requirements
🌥️Trending News LIXTE ($NASDAQ:LIXT) Biotechnology Holdings (LIXTE) has announced a reverse stock split to comply with the minimum price requirements [...]
Oncorus Intrinsic Value Calculation – ONCORUS Facing Bankruptcy as 43% of Employees Laid Off
🌥️Trending News Oncorus ($NASDAQ:ONCR) is a publicly-traded biotechnology company dedicated to the discovery and development of innovative treatments and cures [...]
Adaptimmune Therapeutics Stock Intrinsic Value – ADAPTIMMUNE THERAPEUTICS Reports Q1 Revenue of $47.6M, Exceeding Street Estimate of $4.6M.
🌥️Trending News ADAPTIMMUNE THERAPEUTICS ($NASDAQ:ADAP), a biopharmaceutical company that focuses on developing engineered T-cell therapies, recently reported its Q1 revenue [...]
HOOKIPA Pharma Soars 35% After Pricing $30M Offering
🌥️Trending News HOOKIPA ($NASDAQ:HOOK) Pharma made news recently after its stock rose by 35% after pricing a $30M offering. HOOKIPA [...]
Tyra Biosciences Unveils Novel FGFR3-Selective Molecules for Early Stage Development
☀️Trending News Tyra Biosciences ($NASDAQ:TYRA) is an innovative biotechnology company pioneering the development of FGFR3-specific molecules for early stage development. [...]
Cyclerion Therapeutics Meets Nasdaq’s Minimum Bid Price Requirement
🌥️Trending News Cyclerion Therapeutics ($NASDAQ:CYCN) has recently met the Nasdaq's minimum bid price requirement, which is a positive sign for [...]
